Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
This review provides a comprehensive summary of key 2011 updates in lipid and hypertension management, including major ESC/EAS and ACCF/AHA guidelines.
The year 2011 was very interesting regarding new studies, trials and guidelines in the field of lipidology, hypertensiology and nephrology. Suffice it to mention the new European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias, American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) guidelines on hypertension in the elderly, and many important trials presented among others during the American Society of Nephrology (ASN) Annual Congress in Philadelphia and the AHA Annual Congress in Orlando. The paper is an attempt to summarize the most important events and reports in the mentioned areas in the passing year.
No takes yet. Share an insight, caveat, or question.
Barylski et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: